Submit your views

Continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) technology has changed the lives of tens of thousands of Australians living with type 1 diabetes.

It provides more accurate blood glucose readings more conveniently with less finger prick checks.

While people living with type 1 diabetes are now able to access CGM there are still thousands of Australians who would benefit from this technology but can’t access it because it is too expensive. This includes people living with type 2 diabetes using multiple daily insulin injections, children and young adults (aged under 30 years) living with type 2 diabetes and people living with a range of other types of diabetes and conditions such as cystic fibrosis-related diabetes, pancreatic diabetes, maturity-onset diabetes of young, latent autoimmune diabetes in adults, as well as people who have undergone pancreatectomies or otherwise experience catastrophic pancreatic injuries.

People living with these types of diabetes face health challenges that are very similar to people living with type 1 diabetes. They can also have a much higher risk of diabetes-related complications.

They should be able to access the technology they need to live well. Unfortunately, for many people it is too expensive.

Using the form, share with us how subsidised access to CGM or Flash GM would improve your diabetes management and your quality of life. Diabetes Australia will use your stories to spark change with the Australian Government to ensure more people can access this life-saving technology. 

“As an avid bushwalker, I grew envious as subsidised CGM became available for all Australians with type 1 diabetes as I saw the benefits in being able to monitor myself on a bushwalk without the need to stop, unpack, check and go again.” 

~ Gavin, lives with type 2 diabetes 

“I periodically ‘invest’ in a two-week CGM to see how I’m tracking over longer periods and it would be nice to be able to do this more than once a quarter or once every six months. Isn’t monitoring and prevention a better investment than going down the other path and spending money managing complications after they occur? That’s why I want to spark change for better access to CGM.” 

~ Randy, lives with type 2 diabetes